Clinical Trial Update: Exablate Blood-Brain Barrier Disruption With Carboplatin for the Treatment of rGBM [Phase 1, Phase 2]

View source ↗

Summary

The document reports that a Phase 1/2 clinical trial evaluating Exablate-enabled disruption of the blood-brain barrier with Carboplatin for recurrent glioblasto…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)

Snippet

Sponsor: InSightec | Conditions: Recurrent Glioblastoma | Phase 1, Phase 2 | Status: COMPLETED